164 related articles for article (PubMed ID: 18556884)
41. [Familiarity and heredity of tumors in function of an early surgical therapeutic approach].
Ricevuto E; Di Rocco ZC; Cianci G; Bisegna R; Casilli F; De Galitiis F; Cannita K; Calista F; Porzio G; Bafile A; Vicentini R; Resta V; De Rubeis G; Martinotti S; Ficorella C; Marchetti P
Suppl Tumori; 2002; 1(3):S89-91. PubMed ID: 12415797
[No Abstract] [Full Text] [Related]
42. High-risk women should have BRCA testing.
Cancer Discov; 2014 Feb; 4(2):139. PubMed ID: 24501290
[TBL] [Abstract][Full Text] [Related]
43. Women's experiences of undergoing BRCA1 and BRCA2 testing: organisation of the German Hereditary Breast and Ovarian Cancer Consortium Survey and Preliminary Data from Münster.
Nippert I; Schlegelberger B;
Community Genet; 2003; 6(4):249-58. PubMed ID: 15331871
[TBL] [Abstract][Full Text] [Related]
44. 'Indirect' BRCA1/2 testing: a useful approach in hereditary breast and ovarian cancer families without a living affected relative.
Cruger DG; Kruse TA; Gerdes AM
Clin Genet; 2005 Sep; 68(3):228-33. PubMed ID: 16098011
[TBL] [Abstract][Full Text] [Related]
45. Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and/or ovarian cancer.
Fourati A; Louchez MM; Fournier J; Gamoudi A; Rahal K; El May MV; El May A; Revillion F; Peyrat JP
Bull Cancer; 2014 Nov; 101(11):E36-40. PubMed ID: 25418591
[TBL] [Abstract][Full Text] [Related]
46. Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer.
Forman AD; Hall MJ
Breast J; 2009; 15 Suppl 1():S56-62. PubMed ID: 19775331
[TBL] [Abstract][Full Text] [Related]
47. Progress of a Comprehensive Familial Cancer Genetic Counseling Program in the Era of BRCA1 and BRCA2.
Hartenbach EM; Becker JM; Grosen EA; Bailey HH; Petereit DG; Laxova R; Schink JC
Genet Test; 2002; 6(2):75-8. PubMed ID: 12229876
[TBL] [Abstract][Full Text] [Related]
48. BRCA1 and BRCA2 Testing in Medically Underserved Medicare Beneficiaries With Breast or Ovarian Cancer.
Gross AL; Blot WJ; Visvanathan K
JAMA; 2018 Aug; 320(6):597-598. PubMed ID: 30120466
[TBL] [Abstract][Full Text] [Related]
49. Summaries for patients. Assessing the genetic risk for BRCA-related breast or ovarian cancer in women: recommendations from the U.S. Preventive Services Task Force.
Ann Intern Med; 2014 Feb; 160(4):I-16. PubMed ID: 24366402
[No Abstract] [Full Text] [Related]
50. Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada.
Risch HA; McLaughlin JR; Cole DE; Rosen B; Bradley L; Fan I; Tang J; Li S; Zhang S; Shaw PA; Narod SA
J Natl Cancer Inst; 2006 Dec; 98(23):1694-706. PubMed ID: 17148771
[TBL] [Abstract][Full Text] [Related]
51. Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening.
Paluch-Shimon S; Cardoso F; Sessa C; Balmana J; Cardoso MJ; Gilbert F; Senkus E;
Ann Oncol; 2016 Sep; 27(suppl 5):v103-v110. PubMed ID: 27664246
[No Abstract] [Full Text] [Related]
52. Rapid screening test of most frequent BRCA1/BRCA2 pathogenic variants in the NGS era.
Zidekova D; Waczulikova I; Dolesova L; Vavrova L; Hamidova O; Lohajova Behulova R; Konecny M
Neoplasma; 2018; 65(2):309-315. PubMed ID: 29534594
[TBL] [Abstract][Full Text] [Related]
53. [Genetic predisposition for breast cancer: BRCA1 and BRCA2 genes].
Narod SA; RodrÃguez AA
Salud Publica Mex; 2011; 53(5):420-9. PubMed ID: 22218796
[TBL] [Abstract][Full Text] [Related]
54. Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population.
Meindl A;
Int J Cancer; 2002 Feb; 97(4):472-80. PubMed ID: 11802209
[TBL] [Abstract][Full Text] [Related]
55. Psychosocial issues associated with genetic testing for breast and ovarian cancer risk: an integrative review.
Pasacreta JV
Cancer Invest; 2003; 21(4):588-623. PubMed ID: 14533449
[TBL] [Abstract][Full Text] [Related]
56. BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families.
Antoniou AC; Durocher F; Smith P; Simard J; Easton DF;
Breast Cancer Res; 2006; 8(1):R3. PubMed ID: 16417652
[TBL] [Abstract][Full Text] [Related]
57. Mutations of BRCA genes in hereditary breast and ovarian cancer.
Radice P
J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):9-12. PubMed ID: 12585647
[TBL] [Abstract][Full Text] [Related]
58. Hereditary breast and ovarian cancer syndrome.
ACOG Committee on Practice Bulletins
Gynecol Oncol; 2009 Apr; 113(1):6-11. PubMed ID: 19309638
[No Abstract] [Full Text] [Related]
59. [Genetic predisposition to breast and ovarian cancer: importance of test results].
Julian-Reynier C
Med Sci (Paris); 2011; 27(6-7):657-61. PubMed ID: 21718651
[TBL] [Abstract][Full Text] [Related]
60. Exercise and healty weight in youth delay onset of breast cancer in women at highest risk.
Rollins G
Rep Med Guidel Outcomes Res; 2003 Nov; 14(23):7-8. PubMed ID: 14661631
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
